Shareholders Reject Redomestication to Texas; Approve Equity Incentive Plan
WFRD has more than doubled off its 52-week low of $46.2.
Summary
Weatherford shareholders rejected the proposed redomestication to Texas, a strategic move the company expected to bring significant financial benefits, but approved an increase of 565,000 shares for its equity incentive plan.
Key Events · Corporate Governance and Compliance · WFRD
-
Redomestication Proposal Rejected
Shareholders did not approve the proposed redomestication from Ireland to Texas, failing to meet the requisite 75% support threshold, despite receiving over 60% of votes cast. This follows multiple proxy filings (PRE 14A, DEF 14A, DEFA14A) from April and June 2026 related to this strategic initiative.
-
Equity Incentive Plan Approved
Shareholders approved the Fifth Amended and Restated 2019 Equity Incentive Plan, authorizing the company to issue an additional 565,000 ordinary shares for employee incentives. This represents approximately 0.785% potential dilution based on 71,933,662 outstanding shares.
-
Future Redomestication Plans
The company stated that redomestication remains a priority due to expected financial benefits and intends to present an updated proposal to redomicile to Delaware at a future shareholder meeting.
Analysis · WFRD · Energy & Transportation
Shareholders voted against the company's proposed redomestication from Ireland to Texas, a strategic priority that Weatherford had projected would yield $20-30 million in financial benefits. This rejection represents a significant setback for a key corporate initiative. The company plans to present an updated proposal to redomicile to Delaware in the future. Separately, shareholders approved an increase of 565,000 shares for the equity incentive plan, which represents approximately 0.785% potential dilution based on current outstanding shares.
At the time of this filing, WFRD was trading at $101.03 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $7.3B. The 52-week trading range was $46.20 to $113.15. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.